Boeing's New 737 MAX Failure

Hologic: “Bigger, Faster, Stronger”

Today is Monday, January 8, 2024.

The Early Bird Index today is 62.50.

New to this newsletter? Sign up here

Boeing's New 737 MAX Failure

Aircraft manufacturing giant Boeing (NYSE: BA) is once again in hot water after a hole was torn on a Boeing 737 MAX-9 flight over the weekend.

Details: The U.S. FAA ordered the grounding of most Boeing 737 MAX 9s for safety checks due to the incident. Reuters reported on Sunday that the safety checks hit a snag due to paperwork issues.

Quote: “We agree with and fully support the FAA's decision to require immediate inspections of 737-9 airplanes with the same configuration as the affected airplane.” - Boeing.

Background: This isn’t the first time that the Boeing 737 MAX has faced controversy. The planes were grounded in 2019 due to two crashes, a dark chapter in the history of Boeing.

Stock Price: Boeing is up 19% in the past 12 months. Keep in mind that Boeing’s stock price still has not recovered since the first 737 MAX groundings in 2019.

Also: Boeing may not be the only company in trouble over this incident. Reuters reported that aerospace supplier Spirit AeroSystems (NYSE: SPR) made the part of the plane that malfunctioned over the weekend.

Final Thoughts: This incident could spell trouble for Boeing and other aviation stocks. Boeing reports earnings on January 31.

Hal9 (Sponsored)

Chat with your enterprise databases using secure generative AI and empower business users in your team to do their own data analyses in seconds.


Notable Earnings Today: Accolade (Nasdaq: ACCD), Helen of Troy (Nasdaq: HELE), Jefferies (NYSE: JEF), Commercial Metals Company (NYSE: CMC).

Notable IPOs Today: N/A.

Notable Equity Crowdfunding Campaigns Ending Today: Native Ingredients (Honeycomb), Precycle (Honeycomb), Legion Works (StartEngine).

Notable Economic Events Today: NY Fed 1-Year Consumer Inflation Expectations (11:00 a.m. ET), Consumer Credit (3:00 p.m. ET).

Hologic: “Bigger, Faster, Stronger”

Medical tech company Hologic (Nasdaq: HOLX) reported preliminary financial results on Sunday.

Financials: Hologic reported revenue of $1.01 billion in the quarter, which was better than expected.

Quote: “Each division continues to execute and our preliminary revenue results reinforce that we are a new Hologic; a bigger, faster, stronger company than prior to the pandemic.” - CEO Steve MacMillan.

Background: It’s been a weird year for Hologic. While financials have been mixed, there were rumors about potential leadership changes at one point.

Stock Price: Hologic is down 8% in the last 12 months, but up in the last 30 days.

Final Thoughts: Biotech can be a risky space. Hologic reports its full financial results on February 1.

Bitcoin Ready for Potential Spot ETF Decision

The price of Bitcoin dipped 1% on Sunday, with a potential decision regarding the approval of spot Bitcoin ETFs (exchange-traded funds) in the U.S. coming this week.

Final Thoughts: An approval could be a game-changer for cryptocurrency. In the short term, we’re talking about price increases. In the long term, it could mean added credibility. 

Lifting All Boats: How will Ethereum price react to Bitcoin ETF approval? (Cointelegraph)

Earnings Season: The Stock Rally Has Stalled. Now Comes Earnings Season (Wall Street Journal)

Thank you for reading!

Forward to a friend and tell them to sign up here.

Want more investing tips? Listen to the podcast.

Show Your Support: Buy Me a Coffee.

Questions or comments? Hit reply to reach out.